vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and PCB BANCORP (PCB). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $21.2M, roughly 1.4× Autolus Therapeutics plc). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
AUTL vs PCB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $29.2M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 45.0% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 11.3% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $29.2M | ||
| Q3 25 | $21.2M | $30.4M | ||
| Q2 25 | $20.9M | $29.3M | ||
| Q1 25 | $9.0M | $26.9M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | $0 | $25.3M | ||
| Q2 24 | $0 | $24.2M | ||
| Q1 24 | $10.1M | $23.9M |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $11.4M | ||
| Q2 25 | $-47.9M | $9.1M | ||
| Q1 25 | $-70.2M | $7.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $7.8M | ||
| Q2 24 | $-58.3M | $6.3M | ||
| Q1 24 | $-52.7M | $4.7M |
| Q4 25 | — | 45.0% | ||
| Q3 25 | -337.9% | 52.3% | ||
| Q2 25 | -292.6% | 43.3% | ||
| Q1 25 | -726.3% | 40.2% | ||
| Q4 24 | — | 39.3% | ||
| Q3 24 | — | 42.2% | ||
| Q2 24 | — | 36.3% | ||
| Q1 24 | -384.1% | 27.2% |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 37.5% | ||
| Q2 25 | -229.0% | 31.0% | ||
| Q1 25 | -781.1% | 28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 30.8% | ||
| Q2 24 | — | 25.9% | ||
| Q1 24 | -522.1% | 19.6% |
| Q4 25 | — | $0.65 | ||
| Q3 25 | $-0.30 | $0.78 | ||
| Q2 25 | $-0.18 | $0.62 | ||
| Q1 25 | $-0.26 | $0.53 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | $-0.31 | $0.52 | ||
| Q2 24 | $-0.22 | $0.43 | ||
| Q1 24 | $-0.24 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $390.0M |
| Total Assets | $661.9M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $207.1M | ||
| Q3 25 | $86.1M | $369.5M | ||
| Q2 25 | $123.8M | $263.6M | ||
| Q1 25 | $95.8M | $214.3M | ||
| Q4 24 | — | $198.8M | ||
| Q3 24 | $657.1M | $193.1M | ||
| Q2 24 | $705.9M | $177.6M | ||
| Q1 24 | $758.5M | $239.8M |
| Q4 25 | — | $390.0M | ||
| Q3 25 | $265.5M | $384.5M | ||
| Q2 25 | $346.5M | $376.5M | ||
| Q1 25 | $371.1M | $370.9M | ||
| Q4 24 | — | $363.8M | ||
| Q3 24 | $477.0M | $362.3M | ||
| Q2 24 | $527.8M | $353.5M | ||
| Q1 24 | $582.0M | $350.0M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | $661.9M | $3.4B | ||
| Q2 25 | $721.0M | $3.3B | ||
| Q1 25 | $746.3M | $3.2B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | $827.5M | $2.9B | ||
| Q2 24 | $853.6M | $2.9B | ||
| Q1 24 | $901.4M | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $26.6M |
| Free Cash FlowOCF − Capex | $-72.3M | $24.4M |
| FCF MarginFCF / Revenue | -341.2% | 83.6% |
| Capex IntensityCapex / Revenue | 20.8% | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.6M | ||
| Q3 25 | $-67.9M | $16.4M | ||
| Q2 25 | $-72.8M | $4.9M | ||
| Q1 25 | $-75.6M | $2.3M | ||
| Q4 24 | — | $39.0M | ||
| Q3 24 | $-76.7M | $11.9M | ||
| Q2 24 | $-51.1M | $14.6M | ||
| Q1 24 | $-40.5M | $8.2M |
| Q4 25 | — | $24.4M | ||
| Q3 25 | $-72.3M | $16.2M | ||
| Q2 25 | $-80.1M | $3.8M | ||
| Q1 25 | $-83.8M | $1.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-86.3M | $11.9M | ||
| Q2 24 | $-51.9M | $12.8M | ||
| Q1 24 | $-41.0M | $6.0M |
| Q4 25 | — | 83.6% | ||
| Q3 25 | -341.2% | 53.2% | ||
| Q2 25 | -382.6% | 13.1% | ||
| Q1 25 | -933.1% | 6.0% | ||
| Q4 24 | — | 133.2% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 53.1% | ||
| Q1 24 | -406.8% | 25.2% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | 20.8% | 0.8% | ||
| Q2 25 | 34.8% | 3.7% | ||
| Q1 25 | 91.8% | 2.8% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | 5.3% | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
